272BIO

Beeches Farm Road Maple Barn /

TN22 5QD Uckfield

GB

272BIO

Foundation date

19/07/2019

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

272BIO are developing biotherapeutics, using innovative technologies, for livestock and companion animal disorders. Applying novel technologies, we are able to reduce hitherto prohibitive production costs and produce affordable therapies.  VHH antibodies enable 272BIO to design bespoke drugs for optimal disease control.

Upcoming events

Latest news

  • V-Bio Ventures raises additional capital to support young biotech companies

    1 day ago

  • Galapagos appoints Paul Stoffels as Chief Executive Officer

    1 day ago

  • Biotalys appoints Kwizda Agro as formulator of its protein-based biocontrols

    1 day ago